Omega-3 polyunsaturated fatty acids play a protective role in a mouse model of Parkinson’s disease by increasing intestinal inducible Treg cells
Authors:
Open Access
- 28 April 2024
- journal article
- research article
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 70 (4) , 107-112
Abstract
Parkinsons disease (PD) is defined as a progressive neurodegenerative disease in middle-aged and elderly people. The therapeutic effect of ω-3 PUFAs in several neurodegenerative diseases has been well recognized. Nevertheless, whether nutrition supplementing ω-3 PUFAs exerts a neuroprotective role in PD remains elusive. Bioinformatics revealed 2D chemical structural formula of three components. Mice received indicated treatment with saline, MPTP or ω-3 PUFAs according to grouping. Behavioral function of mice was measured through motor tests such as rearing, akinesia, and rotarod tests. OFT test measured anxiety-like behaviors of mice. Western blotting and TUNEL staining measured dopaminergic fibers and neurons of mice. Western blotting measured inflammation and apoptosis-related protein levels in mouse tissue. FACS measured iTreg cell proportion in colon and brain tissues of mice. ω-3 PUFAs repaired MPTP-stimulated motor function damage in PD mice. ω-3 PUFAs mitigated MPTP-stimulated comorbid anxiety in PD mice. ω-3 PUFAs relieved MPTP-stimulated deficits of dopaminergic fibers and neurons in PD mice. ω-3 PUFAs repressed MPTP-stimulated inflammation and apoptosis pathway activation in PD mice. ω-3 PUFAs repaired MPTP-stimulated immune function damage in PD mice. ω-3 PUFAs exert a protective role in PD mice through alleviating motor function impairment and neuroinflammation by increasing intestinal inducible Treg cells, which may provide a new direction for seeking targeted therapy plans for PD in humans.Keywords
This publication has 39 references indexed in Scilit:
- T cells, α-synuclein and Parkinson disease2022
- Dietary EPA‐Enriched Phospholipids Alleviate Chronic Stress and LPS‐Induced Depression‐ and Anxiety‐Like Behavior by Regulating Immunity and NeuroinflammationMolecular Nutrition & Food Research, 2021
- Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathwayBrain, Behavior, and Immunity, 2021
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisNeurotherapeutics, 2020
- DHA attenuates Aβ-induced necroptosis through the RIPK1/RIPK3 signaling pathway in THP-1 monocytesBiomedicine & Pharmacotherapy, 2020
- Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytesGlia, 2019
- Regulatory T Cells: the Many Faces of Foxp3Journal of Clinical Immunology, 2019
- Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentationsMovement Disorders, 2019
- Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson’s DiseaseNeurochemical Research, 2018
- Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illnessPsychopharmacology, 2016